Abiopharma

Xtant Medical to Announce Second Quarter 2025 Financial Results on August 12, 2025

Lucid Diagnostics to Participate in Upcoming Investor Conferences

Lucid Diagnostics to Participate in Upcoming Investor Conferences

Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2025

Syra Health To Announce Second Quarter 2025 Financial Results

New Form 8-K - Organon & Co. Filed: 2025-08-05 AccNo: 0001104659-25-073929 Size: 6 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 10-Q - ImmunityBio, Inc. Filed: 2025-08-05 AccNo: 0001326110-25-000114 Size: 15 MB

STAA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of STAAR Surgical Company Is Fair to Shareholders

New Form 8-K - Surgery Partners, Inc. Filed: 2025-08-05 AccNo: 0001638833-25-000132 Size: 592 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 6-K - Quantum Biopharma Ltd. Filed: 2025-08-05 AccNo: 0001171843-25-005024 Size: 15 KB

Canopy Growth Press Release - Canopy Growth Expands Global Medical Portfolio with Launch of 7ACRES in Australia

New Form 10-Q - Foghorn Therapeutics Inc. Filed: 2025-08-05 AccNo: 0001628280-25-037606 Size: 5 MB

Surgery Partners, Inc. Announces Second Quarter 2025 Results

Sensei Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

New Form 10-Q - Iterum Therapeutics plc Filed: 2025-08-05 AccNo: 0000950170-25-102400 Size: 12 MB